BCM
Bayesian Capital Management’s Zimmer Biomet ZBH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-26,607
| Closed | -$2.81M | – | 1015 |
|
2024
Q4 | $2.81M | Buy |
26,607
+22,900
| +618% | +$2.42M | 0.34% | 83 |
|
2024
Q3 | $400K | Buy |
+3,707
| New | +$400K | 0.05% | 422 |
|
2023
Q3 | – | Sell |
-20,700
| Closed | -$3.01M | – | 1059 |
|
2023
Q2 | $3.01M | Buy |
20,700
+7,400
| +56% | +$1.08M | 0.32% | 65 |
|
2023
Q1 | $1.72M | Buy |
13,300
+6,226
| +88% | +$804K | 0.21% | 135 |
|
2022
Q4 | $902K | Buy |
+7,074
| New | +$902K | 0.13% | 210 |
|
2022
Q3 | – | Sell |
-9,359
| Closed | -$983K | – | 1058 |
|
2022
Q2 | $983K | Buy |
+9,359
| New | +$983K | 0.18% | 155 |
|
2021
Q3 | – | Sell |
-5,888
| Closed | -$947K | – | 580 |
|
2021
Q2 | $947K | Buy |
+5,888
| New | +$947K | 0.25% | 108 |
|
2020
Q4 | – | Sell |
-3,100
| Closed | -$422K | – | 693 |
|
2020
Q3 | $422K | Sell |
3,100
-2,400
| -44% | -$327K | 0.1% | 265 |
|
2020
Q2 | $656K | Sell |
5,500
-6,000
| -52% | -$716K | 0.14% | 199 |
|
2020
Q1 | $1.16M | Sell |
11,500
-6,300
| -35% | -$637K | 0.25% | 95 |
|
2019
Q4 | $2.66M | Buy |
17,800
+11,000
| +162% | +$1.65M | 0.46% | 41 |
|
2019
Q3 | $933K | Sell |
6,800
-3,700
| -35% | -$508K | 0.18% | 161 |
|
2019
Q2 | $1.24M | Buy |
+10,500
| New | +$1.24M | 0.26% | 110 |
|
2019
Q1 | – | Sell |
-11,500
| Closed | -$1.19M | – | 792 |
|
2018
Q4 | $1.19M | Sell |
11,500
-1,500
| -12% | -$156K | 0.24% | 121 |
|
2018
Q3 | $1.71M | Buy |
+13,000
| New | +$1.71M | 0.28% | 88 |
|
2016
Q4 | – | Sell |
-4,922
| Closed | -$640K | – | 725 |
|
2016
Q3 | $640K | Buy |
+4,922
| New | +$640K | 0.42% | 74 |
|
2016
Q1 | – | Sell |
-6,124
| Closed | -$628K | – | 453 |
|
2015
Q4 | $628K | Buy |
+6,124
| New | +$628K | 0.9% | 9 |
|